Literature DB >> 21954249

Elimination of rubella and congenital rubella syndrome in the Americas.

Carlos Castillo-Solórzano1, Christina Marsigli, Pamela Bravo-Alcántara, Brendan Flannery, Cuauhtémoc Ruiz Matus, Gina Tambini, Socorro Gross-Galiano, Jon Kim Andrus.   

Abstract

In 2003, the Pan American Health Organization (PAHO) adopted a resolution calling for rubella and congenital rubella syndrome (CRS) elimination in the Americas by the year 2010. To accomplish this goal, PAHO advanced a rubella and CRS elimination strategy including introduction of rubella-containing vaccines into routine vaccination programs accompanied by high immunization coverage, interruption of rubella transmission through mass vaccination of adolescents and adults, and strengthened surveillance for rubella and CRS. The rubella elimination strategies were aligned with the successful measles elimination strategies. By the end of 2009, all countries routinely vaccinated children against rubella, an estimated 450 million people had been vaccinated against measles and rubella in supplementary immunization activities, and rubella transmission had been interrupted. This article describes how the region eliminated rubella and CRS.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21954249     DOI: 10.1093/infdis/jir472

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  23 in total

1.  Measles and rubella vaccination coverage in Haiti, 2012: progress towards verifying and challenges to maintaining measles and rubella elimination.

Authors:  Rania A Tohme; Jeannot François; Kathleen Wannemuehler; Roc Magloire; M Carolina Danovaro-Holliday; Brendan Flannery; Kathleen F Cavallaro; David L Fitter; Nora Purcell; Amber Dismer; Jordan W Tappero; John F Vertefeuille; Terri B Hyde
Journal:  Trop Med Int Health       Date:  2014-07-16       Impact factor: 2.622

2.  Congenital rubella syndrome with blueberry muffin lesions and extensive metaphysitis.

Authors:  Mohemmed Ajij; Sushma Nangia; Bhavna Sharma Dubey
Journal:  J Clin Diagn Res       Date:  2014-12-05

3.  Short-term Prediction of the Incidence of Congenital Rubella Syndrome.

Authors:  Yasushi Ohkusa; Tamie Sugawara; Satoru Arai; Hiroshi Satoh; Hideo Okuno; Keiko Tanaka-Taya; Kazunori Oishi
Journal:  PLoS Curr       Date:  2014-10-30

4.  Seroprevalence of anti-mumps virus IgG antibody titer and voluntary mumps vaccination coverage in young adults in Japan.

Authors:  Hiraku Sasaki; Tomoko Fukunaga; Ai Asano; Kansuke Yamanaka; Kota Oikawa; Nobuto Shibata
Journal:  Hum Vaccin Immunother       Date:  2021-04-20       Impact factor: 3.452

Review 5.  Health economics of rubella: a systematic review to assess the value of rubella vaccination.

Authors:  Joseph B Babigumira; Ian Morgan; Ann Levin
Journal:  BMC Public Health       Date:  2013-04-29       Impact factor: 3.295

6.  Differences in Establishment of Persistence of Vaccine and Wild Type Rubella Viruses in Fetal Endothelial Cells.

Authors:  Ludmila Perelygina; Adebola Adebayo; Maureen Metcalfe; Joseph Icenogle
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

7.  Characterization of rubella seronegative females in the zambian blood donor community.

Authors:  Mazyanga L Mazaba; Mwaka Monze; Olusegun A Babaniyi; Seter Siziya; Charles Michelo
Journal:  Front Public Health       Date:  2015-04-24

Review 8.  Using Seroprevalence and Immunisation Coverage Data to Estimate the Global Burden of Congenital Rubella Syndrome, 1996-2010: A Systematic Review.

Authors:  Emilia Vynnycky; Elisabeth J Adams; Felicity T Cutts; Susan E Reef; Ann Marie Navar; Emily Simons; Lay-Myint Yoshida; David W J Brown; Charlotte Jackson; Peter M Strebel; Alya J Dabbagh
Journal:  PLoS One       Date:  2016-03-10       Impact factor: 3.240

9.  Identification of congenital rubella syndrome in Sudan.

Authors:  Omer Adam; Ahmed K M Ali; Judith M Hübschen; Claude P Muller
Journal:  BMC Infect Dis       Date:  2014-06-04       Impact factor: 3.090

10.  [Seroprevalence of rubella in Colombia: a birth-year cohort analysis].

Authors:  Doracelly Hincapie-Palacio; Viviana Lenis Ballesteros; Martha Ospina Ospina; Olga Lucía Pérez Toro; Francisco J Díaz
Journal:  Rev Saude Publica       Date:  2013-12       Impact factor: 2.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.